Valinor and Renew Launch Partnership to Generate Largest Clinical Multi-Omics Dataset for Neurological Disease Model Development
18.03.2026 - 20:00:20 | prnewswire.co.ukAbout Valinor
Valinor is revolutionizing therapeutic R&D by using machine learning combined with proprietary clinical datasets. Valinor is currently developing a suite of patient-derived datasets and foundation models to empower drug developers to predict patient response. By reducing trial-and-error and de-risking development, Valinor aims to accelerate breakthroughs across therapeutic areas and drug modalities. Follow Valinor on LinkedIn and X, and visit ValinorDiscovery.com to learn more about Valinor's approach.
Logo - https://mma.prnewswire.com/media/2918842/Valinor_logo.jpg
Logo - https://mma.prnewswire.com/media/2468598/Renew_Biotechnologies_New.jpg
View original content:https://www.prnewswire.co.uk/news-releases/valinor-and-renew-launch-partnership-to-generate-largest-clinical-multi-omics-dataset-for-neurological-disease-model-development-302695293.html
